Result Summary

• Aster DM Healthcare Ltd reported a 13.6% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Jun (Q1 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 5.8%.
• Its expenses for the quarter were up by 6.9% QoQ and 3.9% YoY.
• The net profit decreased 4411.5% QoQ and decreased 98.2% YoY.
• The earnings per share (EPS) of Aster DM Healthcare Ltd stood at 1.7 during Q1 FY 2025-26.

Financial Statments for Q1 FY 2025-26

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Quarterly Financial Report: Aster DM Healthcare Ltd

Company Overview

Aster DM Healthcare Ltd is a prominent player in the healthcare industry, primarily operating in the Middle East and India. The company offers a wide range of healthcare services, including hospitals, clinics, and pharmacies. Aster DM Healthcare is known for its comprehensive service offerings in the healthcare sector, catering to various patient needs with a focus on quality healthcare delivery. Recently, the company has been expanding its footprint with new hospital projects and enhancing its service capabilities to meet the growing demand for healthcare services in the regions it operates.

Revenue

In the first quarter of the fiscal year 2026 (Q1FY26), Aster DM Healthcare Ltd reported a total income of ₹1111.05 crores. This marks a significant increase of 13.6% compared to the previous quarter (Q4FY25), where the total income was ₹977.67 crores. On a year-over-year basis, the total income grew by 5.8% from ₹1050.59 crores in Q1FY25. This growth in revenue is indicative of the company's efforts to enhance its service offerings and expand its market presence.

Profitability

The company's profit before tax for Q1FY26 stood at ₹142.16 crores, which is an 89.1% increase from the previous quarter's ₹75.18 crores. Year-over-year, this represents a 15.9% increase from ₹122.70 crores in Q1FY25. The tax expense for Q1FY26 was ₹42.88 crores, up 40.3% from ₹30.57 crores in Q4FY25, and increased by 10.0% from ₹38.99 crores in Q1FY25. The profit after tax, however, was ₹93.56 crores, which reflects a sharp decline compared to ₹5152.20 crores reported in Q1FY25. This substantial year-over-year decline is reflected in the earnings per share, which decreased from ₹103.20 to ₹1.70 over the same period.

Operating Metrics

During Q1FY26, Aster DM Healthcare Ltd's total expenses were ₹964.50 crores, showing an increase of 6.9% from the previous quarter's ₹902.49 crores. Compared to Q1FY25, expenses rose by 3.9% from ₹927.89 crores. The company's financial performance in terms of profitability exhibited significant variability, as seen in the profit after tax and earnings per share metrics. The earnings per share in Q1FY26 was notably lower at ₹1.70, compared to a loss of ₹0.50 in Q4FY25 and a substantial figure of ₹103.20 in Q1FY25. Despite the fluctuations in profitability indicators, the company maintained an upward trajectory in its revenue and controlled its expense growth within manageable limits.